Stockreport

Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results  and Provides 2026 Outlook 

Cytek Biosciences, Inc.  (CTKB) 
PDF FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, [Read more]